Collage: a vaccine, a hand holding a test tube and a researcher taking a coronavirus DNA sample from the freezer

Wellcome, with photography by Pedro Vilela / Stringer / Getty Images

Covid-19 vaccines: latest on research

The development and roll out of Covid-19 vaccines was a historic moment and the result of a global, collaborative research effort. But without vaccines distributed equitably all over the world, millions still remain vulnerable to infection and illness.

Covid-19 vaccines explained 

How we're supporting research  

We’re supporting global vaccine research and development efforts through CEPI, the Coalition for Epidemic Preparedness Innovations

CEPI has been funding the development of nine Covid-19 vaccines, including Oxford-AstraZeneca and Moderna, with several others in phase III clinical trials.

The first-generation vaccines we currently have were developed to target the original virus, so we need to know how effective they are against new and emerging variants, and how to guide development of the next generation of vaccines. That's why it's vital to carry on investing in research.

Vaccines for everyone 

Fair global vaccine allocation is the only way to end the Covid-19 pandemic. Jeremy Farrar, Director of Wellcome, explains why world leaders need to recognise this and ensure a truly global vaccination programme is made available to everyone as fast as possible.

To overcome the pandemic, we have to overcome it everywhere in the world. But we will only succeed if vaccines are available and affordable to all countries. 

Here's how governments and international organisations can help make sure that vaccines reach everyone who needs them.

  1. Invest in the ACT-Accelerator. This global collaboration of health organisations, scientists, businesses, civil society, governments and philanthropies, including Wellcome, is working to get lifesaving tests, treatments and vaccines from the laboratory to the front line. An investment of $16.8 billion is still needed in 2021 to fund this work.
  2. Donate excess vaccine doses through COVAX. Rich countries that have secured lots of excess vaccine doses must donate these through COVAX, who will ensure that vaccines go where they are needed most.


Contact us